An engineered bi-function fusion protein (CD86-Fc-NKG2a) to reverse NK cell tolerance of malignant cellsCasey Shuptrine,Taylor SchreiberJOURNAL FOR IMMUNOTHERAPY OF CANCER（2019）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
